Bristol-Myers Squibb Company
Benzofuran derivatives for the treatment of hepatitis C

Last updated:

Abstract:

The disclosure provides compounds of formula (I), including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

17 Mar 2017

Issue date:

2 Nov 2021